Wanbury Ltd.
•₹ 264.85-1.36%
2026-08-21
PROS
- Company has a healthy return on capital (ROCE) of 55.8%
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.1%
- Promoters have been increasing their shareholding - up 3.2pp over 2 years
- Latest quarter profit grew 1200.9% YoY, showing strong momentum
- Operating margins have improved to 11.2% from 7.2%
CONS
- Company has a high debt-to-equity of 3.37x
- Recent results are weak - TTM profit is down 38.0% versus prior year
- A large part of profit comes from other income (41.0% of PBT)
- Receivables are growing faster than sales - a possible quality concern
- Interest coverage is weak at 1.8x - earnings barely cover interest
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | WANBURY | 269.50 | 21.92 | 942.36 | 0.00 | 13.49 | 1200.87 | 163.18 | 24.46 | 35.97 | 14.98 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117 | 124 | 126 | 133 | 146 | 144 | 146 | 140 | 131 | 161 | 133 | 172 | 163 | |
| 120 | 118 | 119 | 119 | 133 | 127 | 124 | 121 | 120 | 141 | 120 | 142 | 139 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 2 | 1 | 0 | -2 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 0 |
| Interest | 3 | 4 | 7 | 8 | 6 | 8 | 8 | 7 | 8 | 10 | 10 | 9 | 8 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 |
| -7 | -1 | -3 | 1 | 5 | 7 | 10 | 34 | 1 | 8 | 1 | 19 | 14 | |
| Tax % | 2.78% | -25.35% | -7.62% | -10.87% | 6.01% | -2.50% | -0.19% | 0.80% | 0.00% | 1.84% | 5.43% | -6.30% | 0.88% |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 7 | 10 | 34 | 1 | 8 | 1 | 20 | 13 |
| -2 | -0 | -1 | 0 | 1 | 2 | 3 | 10 | 0 | 2 | 0 | 6 | 4 | |
| Equity Capital | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2022
- 117
- 120
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 3
- Depreciation
- 3
- -7
- Tax %
- 2.78%
- Net Profit
- 0
- -2
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2022
- 124
- 118
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 4
- Depreciation
- 3
- -1
- Tax %
- -25.35%
- Net Profit
- 0
- -0
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2022
- 126
- 119
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 7
- Depreciation
- 3
- -3
- Tax %
- -7.62%
- Net Profit
- 0
- -1
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2023
- 133
- 119
- Operating Profit
- —
- OPM %
- —
- Other Income
- -2
- Interest
- 8
- Depreciation
- 3
- 1
- Tax %
- -10.87%
- Net Profit
- 0
- 0
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2023
- 146
- 133
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 6
- Depreciation
- 3
- 5
- Tax %
- 6.01%
- Net Profit
- 0
- 1
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 144
- 127
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 8
- Depreciation
- 3
- 7
- Tax %
- -2.50%
- Net Profit
- 7
- 2
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 146
- 124
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 8
- Depreciation
- 3
- 10
- Tax %
- -0.19%
- Net Profit
- 10
- 3
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 140
- 121
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 7
- Depreciation
- 3
- 34
- Tax %
- 0.80%
- Net Profit
- 34
- 10
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 131
- 120
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 8
- Depreciation
- 3
- 1
- Tax %
- 0.00%
- Net Profit
- 1
- 0
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 161
- 141
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 10
- Depreciation
- 3
- 8
- Tax %
- 1.84%
- Net Profit
- 8
- 2
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 133
- 120
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 10
- Depreciation
- 3
- 1
- Tax %
- 5.43%
- Net Profit
- 1
- 0
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 172
- 142
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 9
- Depreciation
- 3
- 19
- Tax %
- -6.30%
- Net Profit
- 20
- 6
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 163
- 139
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 8
- Depreciation
- 4
- 14
- Tax %
- 0.88%
- Net Profit
- 13
- 4
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 33
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 423 | 434 | 371 | 391 | 367 | 393 | 511 | 500 | 578 | 600 | 630 | |
| 391 | 415 | 439 | 378 | 389 | 377 | 479 | 477 | 506 | 532 | 542 | |
| Operating Profit | 34 | 108 | 9 | 25 | 25 | 20 | 37 | 24 | 73 | 80 | — |
| OPM % | 8 | 25 | 2 | 6 | 7 | 5 | 7 | 5 | 13 | 13 | — |
| Other Income | 1 | 90 | 77 | 12 | 46 | 5 | 5 | 1 | 1 | 12 | 5 |
| Interest | 32 | 36 | 31 | 40 | 33 | 23 | 21 | 21 | 29 | 37 | 37 |
| Depreciation | 9 | 10 | 10 | 10 | 10 | 10 | 11 | 12 | 13 | 13 | 14 |
| -7 | 62 | -32 | -25 | 65 | -12 | 81 | -10 | 56 | 30 | 42 | |
| Tax % | 0 | 1 | 1 | 1 | 0 | -2 | -0 | -1 | 1 | -3 | -2 |
| Net Profit | -7 | 62 | -32 | -25 | 64 | -13 | 81 | -10 | 56 | 31 | 43 |
| EPS | 0 | 0 | 0 | 0 | 0 | -5 | 2 | -3 | 17 | 9 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -4 | 27 | -13 | -10 | 26 | -5 | 25 | -3 | 17 | 9 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -4 | 27 | -13 | -10 | 26 | -5 | 25 | -3 | 17 | 9 | — |
Mar 2016
- 423
- 391
- Operating Profit
- 34
- OPM %
- 8
- Other Income
- 1
- Interest
- 32
- Depreciation
- 9
- -7
- Tax %
- 0
- Net Profit
- -7
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -4
Mar 2017
- 434
- 415
- Operating Profit
- 108
- OPM %
- 25
- Other Income
- 90
- Interest
- 36
- Depreciation
- 10
- 62
- Tax %
- 1
- Net Profit
- 62
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 27
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 27
Mar 2018
- 371
- 439
- Operating Profit
- 9
- OPM %
- 2
- Other Income
- 77
- Interest
- 31
- Depreciation
- 10
- -32
- Tax %
- 1
- Net Profit
- -32
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -13
Mar 2019
- 391
- 378
- Operating Profit
- 25
- OPM %
- 6
- Other Income
- 12
- Interest
- 40
- Depreciation
- 10
- -25
- Tax %
- 1
- Net Profit
- -25
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -10
Mar 2020
- 367
- 389
- Operating Profit
- 25
- OPM %
- 7
- Other Income
- 46
- Interest
- 33
- Depreciation
- 10
- 65
- Tax %
- 0
- Net Profit
- 64
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 26
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 26
Mar 2021
- 393
- 377
- Operating Profit
- 20
- OPM %
- 5
- Other Income
- 5
- Interest
- 23
- Depreciation
- 10
- -12
- Tax %
- -2
- Net Profit
- -13
- EPS
- -5
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -5
Mar 2022
- 511
- 479
- Operating Profit
- 37
- OPM %
- 7
- Other Income
- 5
- Interest
- 21
- Depreciation
- 11
- 81
- Tax %
- -0
- Net Profit
- 81
- EPS
- 2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 25
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 25
Mar 2023
- 500
- 477
- Operating Profit
- 24
- OPM %
- 5
- Other Income
- 1
- Interest
- 21
- Depreciation
- 12
- -10
- Tax %
- -1
- Net Profit
- -10
- EPS
- -3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -3
Mar 2024
- 578
- 506
- Operating Profit
- 73
- OPM %
- 13
- Other Income
- 1
- Interest
- 29
- Depreciation
- 13
- 56
- Tax %
- 1
- Net Profit
- 56
- EPS
- 17
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 17
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 17
Mar 2025
- 600
- 532
- Operating Profit
- 80
- OPM %
- 13
- Other Income
- 12
- Interest
- 37
- Depreciation
- 13
- 30
- Tax %
- -3
- Net Profit
- 31
- EPS
- 9
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
TTM
- 630
- 542
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 37
- Depreciation
- 14
- 42
- Tax %
- -2
- Net Profit
- 43
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 9%
- 5 Years:
- 10%
- 3 Years:
- 5%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 25%
- 5 Years:
- -14%
- 3 Years:
- -28%
STOCK PRICE CAGR
- 10 Years:
- 20%
- 5 Years:
- 28%
- 3 Years:
- 68%
- 1 Year:
- -4%
RETURN ON EQUITY
- 10 Years:
- 8%
- 5 Years:
- 17%
- 3 Years:
- 28%
- Last Year:
- 84%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 20 | 23 | 24 | 24 | 25 | 25 | 33 | 33 | 33 | 33 |
| -221 | -176 | -209 | -233 | -169 | -182 | -57 | -67 | -12 | 19 | |
| 91 | 63 | 83 | 129 | 77 | 88 | 67 | 64 | 14 | 4 | |
| Trade Payables | 86 | 140 | 83 | 112 | 122 | 134 | 180 | 149 | 163 | 138 |
| 412 | 359 | 288 | 251 | 220 | 218 | 125 | 120 | 139 | 213 | |
| Total Liabilities | 388 | 409 | 269 | 283 | 275 | 284 | 347 | 298 | 338 | 407 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 180 | 186 | 178 | 172 | 164 | 167 | 167 | 167 | 167 | 201 | |
| Capital Work in Progress | 14 | 10 | 10 | 9 | 14 | 11 | 2 | 2 | 3 | 5 |
| 35 | 34 | 13 | 19 | 12 | 25 | 50 | 22 | 36 | 38 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 89 | 114 | |
| Cash & Bank | 7 | 9 | 6 | 5 | 17 | 12 | 25 | 4 | 6 | 13 |
| 151 | 169 | 62 | 77 | 69 | 69 | 102 | 103 | 37 | 36 | |
| Total Assets | 388 | 409 | 269 | 283 | 275 | 284 | 347 | 298 | 338 | 407 |
| Total Debt | 373 | 270 | 220 | 233 | 164 | 160 | 67 | 64 | 109 | 173 |
| Net Working Capital | -135 | -210 | -271 | -263 | -217 | -258 | -189 | -198 | -52 | 19 |
| Contingent Liabilities | 83 | 467 | 548 | 533 | 1,012 | 889 | 934 | 1,072 | 60 | 65 |
| Book Value per Share | -112.21 | -66.01 | -77.97 | -88.32 | -57.48 | -62.60 | -7.55 | -10.57 | 6.44 | 15.69 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 373 | 270 | 220 | 233 | 164 | 160 | 67 | 64 | 109 | 173 |
| Net Working Capital | -135 | -210 | -271 | -263 | -217 | -258 | -189 | -198 | -52 | 19 |
| Contingent Liabilities | 83 | 467 | 548 | 533 | 1,012 | 889 | 934 | 1,072 | 60 | 65 |
| Book Value per Share | -112.21 | -66.01 | -77.97 | -88.32 | -57.48 | -62.60 | -7.55 | -10.57 | 6.44 | 15.69 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2016
- Equity Capital
- 20
- -221
- 91
- Trade Payables
- 86
- 412
- Total Liabilities
- 388
- 180
- Capital Work in Progress
- 14
- 35
- 0
- Cash & Bank
- 7
- 151
- Total Assets
- 388
- Total Debt
- 373
- Net Working Capital
- -135
- Contingent Liabilities
- 83
- Book Value per Share
- -112.21
- Face Value
- 10.00
- Total Debt
- 373
- Net Working Capital
- -135
- Contingent Liabilities
- 83
- Book Value per Share
- -112.21
- Face Value
- 10.00
Mar 2017
- Equity Capital
- 23
- -176
- 63
- Trade Payables
- 140
- 359
- Total Liabilities
- 409
- 186
- Capital Work in Progress
- 10
- 34
- 0
- Cash & Bank
- 9
- 169
- Total Assets
- 409
- Total Debt
- 270
- Net Working Capital
- -210
- Contingent Liabilities
- 467
- Book Value per Share
- -66.01
- Face Value
- 10.00
- Total Debt
- 270
- Net Working Capital
- -210
- Contingent Liabilities
- 467
- Book Value per Share
- -66.01
- Face Value
- 10.00
Mar 2018
- Equity Capital
- 24
- -209
- 83
- Trade Payables
- 83
- 288
- Total Liabilities
- 269
- 178
- Capital Work in Progress
- 10
- 13
- 0
- Cash & Bank
- 6
- 62
- Total Assets
- 269
- Total Debt
- 220
- Net Working Capital
- -271
- Contingent Liabilities
- 548
- Book Value per Share
- -77.97
- Face Value
- 10.00
- Total Debt
- 220
- Net Working Capital
- -271
- Contingent Liabilities
- 548
- Book Value per Share
- -77.97
- Face Value
- 10.00
Mar 2019
- Equity Capital
- 24
- -233
- 129
- Trade Payables
- 112
- 251
- Total Liabilities
- 283
- 172
- Capital Work in Progress
- 9
- 19
- 0
- Cash & Bank
- 5
- 77
- Total Assets
- 283
- Total Debt
- 233
- Net Working Capital
- -263
- Contingent Liabilities
- 533
- Book Value per Share
- -88.32
- Face Value
- 10.00
- Total Debt
- 233
- Net Working Capital
- -263
- Contingent Liabilities
- 533
- Book Value per Share
- -88.32
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 25
- -169
- 77
- Trade Payables
- 122
- 220
- Total Liabilities
- 275
- 164
- Capital Work in Progress
- 14
- 12
- 0
- Cash & Bank
- 17
- 69
- Total Assets
- 275
- Total Debt
- 164
- Net Working Capital
- -217
- Contingent Liabilities
- 1,012
- Book Value per Share
- -57.48
- Face Value
- 10.00
- Total Debt
- 164
- Net Working Capital
- -217
- Contingent Liabilities
- 1,012
- Book Value per Share
- -57.48
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 25
- -182
- 88
- Trade Payables
- 134
- 218
- Total Liabilities
- 284
- 167
- Capital Work in Progress
- 11
- 25
- 0
- Cash & Bank
- 12
- 69
- Total Assets
- 284
- Total Debt
- 160
- Net Working Capital
- -258
- Contingent Liabilities
- 889
- Book Value per Share
- -62.60
- Face Value
- 10.00
- Total Debt
- 160
- Net Working Capital
- -258
- Contingent Liabilities
- 889
- Book Value per Share
- -62.60
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 33
- -57
- 67
- Trade Payables
- 180
- 125
- Total Liabilities
- 347
- 167
- Capital Work in Progress
- 2
- 50
- 0
- Cash & Bank
- 25
- 102
- Total Assets
- 347
- Total Debt
- 67
- Net Working Capital
- -189
- Contingent Liabilities
- 934
- Book Value per Share
- -7.55
- Face Value
- 10.00
- Total Debt
- 67
- Net Working Capital
- -189
- Contingent Liabilities
- 934
- Book Value per Share
- -7.55
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 33
- -67
- 64
- Trade Payables
- 149
- 120
- Total Liabilities
- 298
- 167
- Capital Work in Progress
- 2
- 22
- 0
- Cash & Bank
- 4
- 103
- Total Assets
- 298
- Total Debt
- 64
- Net Working Capital
- -198
- Contingent Liabilities
- 1,072
- Book Value per Share
- -10.57
- Face Value
- 10.00
- Total Debt
- 64
- Net Working Capital
- -198
- Contingent Liabilities
- 1,072
- Book Value per Share
- -10.57
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 33
- -12
- 14
- Trade Payables
- 163
- 139
- Total Liabilities
- 338
- 167
- Capital Work in Progress
- 3
- 36
- 89
- Cash & Bank
- 6
- 37
- Total Assets
- 338
- Total Debt
- 109
- Net Working Capital
- -52
- Contingent Liabilities
- 60
- Book Value per Share
- 6.44
- Face Value
- 10.00
- Total Debt
- 109
- Net Working Capital
- -52
- Contingent Liabilities
- 60
- Book Value per Share
- 6.44
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 33
- 19
- 4
- Trade Payables
- 138
- 213
- Total Liabilities
- 407
- 201
- Capital Work in Progress
- 5
- 38
- 114
- Cash & Bank
- 13
- 36
- Total Assets
- 407
- Total Debt
- 173
- Net Working Capital
- 19
- Contingent Liabilities
- 65
- Book Value per Share
- 15.69
- Face Value
- 10.00
- Total Debt
- 173
- Net Working Capital
- 19
- Contingent Liabilities
- 65
- Book Value per Share
- 15.69
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 43 | 43 | 32 | 30 | 44 | 17 | 41 | 20 | 5 | 26 | |
| Cash from Investing | -20 | -13 | -1 | -3 | 64 | 8 | 1 | -9 | -17 | -51 |
| Cash from Financing | -28 | -27 | -33 | -27 | -108 | -17 | -29 | -32 | 14 | 26 |
| -5 | 3 | -2 | -0 | -0 | 7 | 13 | -21 | 2 | 1 | |
| Free Cash Flow | 27 | 43 | 30 | 27 | 38 | 7 | 38 | 8 | -6 | -21 |
| OCF / Net Profit | -6.02 | 0.70 | -1.02 | -1.20 | 0.68 | -1.32 | 0.50 | -1.90 | 0.08 | 0.85 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 166 | 146 | 140 | 119 | 85 | 27 |
| OCF / Net Profit | -6.02 | 0.70 | -1.02 | -1.20 | 0.68 | -1.32 | 0.50 | -1.90 | 0.08 | 0.85 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 166 | 146 | 140 | 119 | 85 | 27 |
Mar 2016
- 43
- Cash from Investing
- -20
- Cash from Financing
- -28
- -5
- Free Cash Flow
- 27
- OCF / Net Profit
- -6.02
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -6.02
- Cumulative 5-Year FCF
- 0
Mar 2017
- 43
- Cash from Investing
- -13
- Cash from Financing
- -27
- 3
- Free Cash Flow
- 43
- OCF / Net Profit
- 0.70
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.70
- Cumulative 5-Year FCF
- 0
Mar 2018
- 32
- Cash from Investing
- -1
- Cash from Financing
- -33
- -2
- Free Cash Flow
- 30
- OCF / Net Profit
- -1.02
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.02
- Cumulative 5-Year FCF
- 0
Mar 2019
- 30
- Cash from Investing
- -3
- Cash from Financing
- -27
- -0
- Free Cash Flow
- 27
- OCF / Net Profit
- -1.20
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.20
- Cumulative 5-Year FCF
- 0
Mar 2020
- 44
- Cash from Investing
- 64
- Cash from Financing
- -108
- -0
- Free Cash Flow
- 38
- OCF / Net Profit
- 0.68
- Cumulative 5-Year FCF
- 166
- OCF / Net Profit
- 0.68
- Cumulative 5-Year FCF
- 166
Mar 2021
- 17
- Cash from Investing
- 8
- Cash from Financing
- -17
- 7
- Free Cash Flow
- 7
- OCF / Net Profit
- -1.32
- Cumulative 5-Year FCF
- 146
- OCF / Net Profit
- -1.32
- Cumulative 5-Year FCF
- 146
Mar 2022
- 41
- Cash from Investing
- 1
- Cash from Financing
- -29
- 13
- Free Cash Flow
- 38
- OCF / Net Profit
- 0.50
- Cumulative 5-Year FCF
- 140
- OCF / Net Profit
- 0.50
- Cumulative 5-Year FCF
- 140
Mar 2023
- 20
- Cash from Investing
- -9
- Cash from Financing
- -32
- -21
- Free Cash Flow
- 8
- OCF / Net Profit
- -1.90
- Cumulative 5-Year FCF
- 119
- OCF / Net Profit
- -1.90
- Cumulative 5-Year FCF
- 119
Mar 2024
- 5
- Cash from Investing
- -17
- Cash from Financing
- 14
- 2
- Free Cash Flow
- -6
- OCF / Net Profit
- 0.08
- Cumulative 5-Year FCF
- 85
- OCF / Net Profit
- 0.08
- Cumulative 5-Year FCF
- 85
Mar 2025
- 26
- Cash from Investing
- -51
- Cash from Financing
- 26
- 1
- Free Cash Flow
- -21
- OCF / Net Profit
- 0.85
- Cumulative 5-Year FCF
- 27
- OCF / Net Profit
- 0.85
- Cumulative 5-Year FCF
- 27
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | -3.58 | 26.71 | -13.49 | -10.48 | 25.79 | -5.04 | 24.94 | -3.18 | 17.09 | 9.32 |
| Book Value (₹) | -112.21 | -66.01 | -77.97 | -88.32 | -57.48 | -62.60 | -7.55 | -10.57 | 6.44 | 15.69 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 0.95 | 31.15 | -9.15 | -6.27 | 29.66 | -1.14 | 28.45 | 0.61 | 21.07 | 13.38 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 7.79% | 24.39% | 2.22% | 5.98% | 6.63% | 5.18% | 7.16% | 4.73% | 12.37% | 11.22% |
| Net Margin % | -1.65% | 13.98% | -8.09% | -5.97% | 17.38% | -3.20% | 15.83% | -2.04% | 9.60% | 5.06% |
| ROE % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 84.21% |
| ROCE % | 15.27% | 70.48% | -2.00% | 50.26% | 444.45% | 87.61% | 428.78% | 29.82% | 101.56% | 35.97% |
| -1.82% | 15.57% | -9.44% | -9.00% | 23.10% | -4.51% | 25.85% | -3.22% | 17.61% | 8.20% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 73 | 66 | 53 | 32 | 47 | 39 | 34 | 47 | 49 | 61 |
| Inventory Days | 29 | 28 | 22 | 14 | 16 | 17 | 26 | 26 | 18 | 22 |
| Payable Days | 185 | 210 | 234 | 182 | 243 | 211 | 190 | 197 | 187 | 187 |
| -84 | -116 | -160 | -135 | -181 | -154 | -129 | -124 | -120 | -103 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | -1.67x | -1.76x | -1.19x | -1.11x | -1.14x | -1.02x | -2.72x | -1.86x | 5.18x | 3.37x |
| Interest Coverage (x) | 0.78x | 2.76x | -0.05x | 0.37x | 2.97x | 0.46x | 4.94x | 0.52x | 2.93x | 1.80x |
| 0.55x | 0.48x | 0.22x | 0.27x | 0.30x | 0.27x | 0.48x | 0.38x | 0.75x | 1.11x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 69.36% | 2.49% | -14.45% | 5.46% | -6.11% | 6.82% | 30.23% | -2.26% | 15.63% | 3.77% |
| Operating Profit Growth % | 21.02% | 220.43% | -91.89% | 183.27% | -1.14% | -16.93% | 80.29% | -34.59% | 203.06% | 9.34% |
| Net Profit Growth % | -323.06% | 967.78% | -151.61% | 22.37% | 359.43% | -119.56% | 746.33% | -112.76% | 638.26% | -45.44% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 637.60% | -45.48% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 8.54x | 25.19x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 22.63x | 14.96x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 7.96x | 11.64x |
Mar 2016
- EPS (₹)
- -3.58
- Book Value (₹)
- -112.21
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.95
- Operating Margin %
- 7.79%
- Net Margin %
- -1.65%
- ROE %
- 0.00%
- ROCE %
- 15.27%
- -1.82%
- Debtor Days
- 73
- Inventory Days
- 29
- Payable Days
- 185
- -84
- Debt to Equity (x)
- -1.67x
- Interest Coverage (x)
- 0.78x
- 0.55x
- Revenue Growth %
- 69.36%
- Operating Profit Growth %
- 21.02%
- Net Profit Growth %
- -323.06%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2017
- EPS (₹)
- 26.71
- Book Value (₹)
- -66.01
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 31.15
- Operating Margin %
- 24.39%
- Net Margin %
- 13.98%
- ROE %
- 0.00%
- ROCE %
- 70.48%
- 15.57%
- Debtor Days
- 66
- Inventory Days
- 28
- Payable Days
- 210
- -116
- Debt to Equity (x)
- -1.76x
- Interest Coverage (x)
- 2.76x
- 0.48x
- Revenue Growth %
- 2.49%
- Operating Profit Growth %
- 220.43%
- Net Profit Growth %
- 967.78%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- -13.49
- Book Value (₹)
- -77.97
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -9.15
- Operating Margin %
- 2.22%
- Net Margin %
- -8.09%
- ROE %
- 0.00%
- ROCE %
- -2.00%
- -9.44%
- Debtor Days
- 53
- Inventory Days
- 22
- Payable Days
- 234
- -160
- Debt to Equity (x)
- -1.19x
- Interest Coverage (x)
- -0.05x
- 0.22x
- Revenue Growth %
- -14.45%
- Operating Profit Growth %
- -91.89%
- Net Profit Growth %
- -151.61%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- -10.48
- Book Value (₹)
- -88.32
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -6.27
- Operating Margin %
- 5.98%
- Net Margin %
- -5.97%
- ROE %
- 0.00%
- ROCE %
- 50.26%
- -9.00%
- Debtor Days
- 32
- Inventory Days
- 14
- Payable Days
- 182
- -135
- Debt to Equity (x)
- -1.11x
- Interest Coverage (x)
- 0.37x
- 0.27x
- Revenue Growth %
- 5.46%
- Operating Profit Growth %
- 183.27%
- Net Profit Growth %
- 22.37%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 25.79
- Book Value (₹)
- -57.48
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 29.66
- Operating Margin %
- 6.63%
- Net Margin %
- 17.38%
- ROE %
- 0.00%
- ROCE %
- 444.45%
- 23.10%
- Debtor Days
- 47
- Inventory Days
- 16
- Payable Days
- 243
- -181
- Debt to Equity (x)
- -1.14x
- Interest Coverage (x)
- 2.97x
- 0.30x
- Revenue Growth %
- -6.11%
- Operating Profit Growth %
- -1.14%
- Net Profit Growth %
- 359.43%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- -5.04
- Book Value (₹)
- -62.60
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -1.14
- Operating Margin %
- 5.18%
- Net Margin %
- -3.20%
- ROE %
- 0.00%
- ROCE %
- 87.61%
- -4.51%
- Debtor Days
- 39
- Inventory Days
- 17
- Payable Days
- 211
- -154
- Debt to Equity (x)
- -1.02x
- Interest Coverage (x)
- 0.46x
- 0.27x
- Revenue Growth %
- 6.82%
- Operating Profit Growth %
- -16.93%
- Net Profit Growth %
- -119.56%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 24.94
- Book Value (₹)
- -7.55
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 28.45
- Operating Margin %
- 7.16%
- Net Margin %
- 15.83%
- ROE %
- 0.00%
- ROCE %
- 428.78%
- 25.85%
- Debtor Days
- 34
- Inventory Days
- 26
- Payable Days
- 190
- -129
- Debt to Equity (x)
- -2.72x
- Interest Coverage (x)
- 4.94x
- 0.48x
- Revenue Growth %
- 30.23%
- Operating Profit Growth %
- 80.29%
- Net Profit Growth %
- 746.33%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- -3.18
- Book Value (₹)
- -10.57
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.61
- Operating Margin %
- 4.73%
- Net Margin %
- -2.04%
- ROE %
- 0.00%
- ROCE %
- 29.82%
- -3.22%
- Debtor Days
- 47
- Inventory Days
- 26
- Payable Days
- 197
- -124
- Debt to Equity (x)
- -1.86x
- Interest Coverage (x)
- 0.52x
- 0.38x
- Revenue Growth %
- -2.26%
- Operating Profit Growth %
- -34.59%
- Net Profit Growth %
- -112.76%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 17.09
- Book Value (₹)
- 6.44
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 21.07
- Operating Margin %
- 12.37%
- Net Margin %
- 9.60%
- ROE %
- 0.00%
- ROCE %
- 101.56%
- 17.61%
- Debtor Days
- 49
- Inventory Days
- 18
- Payable Days
- 187
- -120
- Debt to Equity (x)
- 5.18x
- Interest Coverage (x)
- 2.93x
- 0.75x
- Revenue Growth %
- 15.63%
- Operating Profit Growth %
- 203.06%
- Net Profit Growth %
- 638.26%
- 637.60%
- P/E (x)
- 8.54x
- P/B (x)
- 22.63x
- Dividend Yield %
- 0.00%
- 7.96x
Mar 2025
- EPS (₹)
- 9.32
- Book Value (₹)
- 15.69
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 13.38
- Operating Margin %
- 11.22%
- Net Margin %
- 5.06%
- ROE %
- 84.21%
- ROCE %
- 35.97%
- 8.20%
- Debtor Days
- 61
- Inventory Days
- 22
- Payable Days
- 187
- -103
- Debt to Equity (x)
- 3.37x
- Interest Coverage (x)
- 1.80x
- 1.11x
- Revenue Growth %
- 3.77%
- Operating Profit Growth %
- 9.34%
- Net Profit Growth %
- -45.44%
- -45.48%
- P/E (x)
- 25.19x
- P/B (x)
- 14.96x
- Dividend Yield %
- 0.00%
- 11.64x
Documents
Announcements
- Press Release
2026-08-13 - Wanbury Limited has informed the Exchange regarding a press release dated August 13, 2026, titled "Press Release regarding EDQM Approval for new product Rivaroxaban API,USFDA DMF Clearances".
- Press Release
2026-08-11 - Wanbury Limited has informed the Exchange regarding a press release dated August 11, 2026, titled "Press release on Un-audited Financial Results for the quarter ended 30 June, 2026".
Annual Reports
Credit Ratings
Nothing filed yet.